Morgan Stanley »

Ernexa Therapeutics shares owned by Morgan Stanley

Quarter-by-quarter ownership of Ernexa Therapeutics (ERNA) shares owned by Morgan Stanley from 13F filings

Historical chart of Morgan Stanley investment in Ernexa Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Ernexa Therapeutics held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ernexa Therapeutics by Morgan Stanley

Quarter filed Position value Share count Share price at filing
2025-06-30 $1.0k 554 1.84

More positions owned by Morgan Stanley

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)
Visa Com Cl A (V)
Ishares Tr Core S&p500 Etf (IVV)
Tesla Motors (TSLA)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Alphabet Cap Stk Cl C (GOOG)

View all positions for Morgan Stanley

Top funds holding Ernexa Therapeutics

CI Private Wealth
Susquehanna International
Geode Capital Management
Vanguard Group
Sippican Capital Adivsors
Tower Research Capital
BlackRock
Morgan Stanley
Assetmark
EverSource Wealth Advisors
Bnp Paribas Arbitrage, Snc
A. Montag and Associates
Activest Wealth Management

View all funds holding Ernexa Therapeutics